Breaking News Instant updates and real-time market news.

FTFT

Future FinTech

$2.58 /

-0.03 (-1.15%)

08:03
09/03/21
09/03
08:03
09/03/21
08:03

Future FinTech signs term sheet to aquire 51% stake in Dianfa Technology

Future FinTech announced that on August 30, the company signed an equity acquisition term sheet to acquire 51% of the equity of Shanghai Dianfa Internet Technology Co., Ltd. The term sheet represents terms for a proposed transaction subject to definitive documentation and is non-binding except for its 'Exclusive Period' and 'Confidentiality'; and 'Governing Law' sections. According to the Term Sheet, the company plans to acquire 51% of the equity of Dianfa Technology at a purchase price of approximately $2,762,730 of which approximately $928,650 will be paid in cash as a capital investment in Dianfa Technology and approximately $1,834,080 will be paid in shares of FTFT common stock to the selling shareholders of Dianfa Technology. The acquisition will be subject to legal and financial due diligence on the part of the company.

TODAY'S FREE FLY STORIES

Upgrade
Marvell upgraded to Outperform after 'watershed' quarter at Cowen » 05:57
12/03/21
12/03
05:57
12/03/21
05:57
MRVL

Marvell

$71.02 /

+0.18 (+0.25%)

Cowen analyst Karl…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

05:40 Today Cowen
Marvell upgraded to Outperform from Market Perform at Cowen
05:11 Today Oppenheimer
Marvell price target raised to $110 from $100 at Oppenheimer
12/01/21 Susquehanna
Marvell price target raised to $82 from $75 at Susquehanna
11/30/21 BMO Capital
Marvell price target raised to $85 from $70 at BMO Capital
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

Downgrade
Smith & Wesson downgraded to Market Perform on 'big miss' at Cowen » 05:55
12/03/21
12/03
05:55
12/03/21
05:55
SWBI

Smith & Wesson Brands

$22.94 /

+0.405 (+1.80%)

Cowen analyst Cai von…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

05:38 Today Cowen
Smith & Wesson downgraded to Market Perform from Outperform at Cowen
09/02/21 Lake Street
Smith & Wesson undervalued after 'another strong quarter,' says Lake Street
06/21/21 Lake Street
Smith & Wesson Brands price target raised to $43 from $34 at Lake Street
03/05/21
Fly Intel: Top five analyst downgrades
SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

Initiation
Peloton initiated with a Buy at Deutsche Bank » 05:52
12/03/21
12/03
05:52
12/03/21
05:52
PTON

Peloton

$44.45 /

+2.14 (+5.06%)

Deutsche Bank analyst…

Deutsche Bank analyst Chris Woronka initiated coverage of Peloton Interactive with a Buy rating and $76 price target. While there there are scenarios in which Peloton shares go lower from here, there are more scenarios that result in greater upside based on a "fundamental and unemotional analysis" of the company's earnings power in a "normalized," fully-reopened economic environment, Woronka tells investors in a research note. The analyst thinks the hybrid work model extends to fitness and that Peloton "has plenty of momentum to regain operationally." If the stock "can regain its footing for fundamental reasons, it has quite a bit of room to run," contends Woronka.

ShowHide Related Items >><<
PTON Peloton
$44.45 /

+2.14 (+5.06%)

PTON Peloton
$44.45 /

+2.14 (+5.06%)

11/29/21 Stifel
Peloton price target lowered to $56 from $70 at Stifel
11/16/21 Baird
Baird adds Peloton as 'Fresh Pick,' says capital raise removes overhang
11/16/21 BMO Capital
Peloton 'backpedaling again' with $1B offering, says BMO Capital
11/11/21 RBC Capital
Affirm price target raised to $175 from $130 at RBC Capital
PTON Peloton
$44.45 /

+2.14 (+5.06%)

  • 16
    Nov
PTON Peloton
$44.45 /

+2.14 (+5.06%)

PTON Peloton
$44.45 /

+2.14 (+5.06%)

PTON Peloton
$44.45 /

+2.14 (+5.06%)

Upgrade
Raymond James upgrades Fastly on selloff, uptick in traffic » 05:50
12/03/21
12/03
05:50
12/03/21
05:50
FSLY

Fastly

$36.47 /

+0.365 (+1.01%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSLY Fastly
$36.47 /

+0.365 (+1.01%)

FSLY Fastly
$36.47 /

+0.365 (+1.01%)

04:50 Today Raymond James
Fastly upgraded to Outperform from Market Perform at Raymond James
09/08/21 Evercore ISI
Evercore says Akamai, Cloudflare, Fastly may partner with Apple on new service
08/09/21 Raymond James
Fastly reinstated with a Market Perform at Raymond James
08/05/21
Fly Intel: Top five analyst downgrades
FSLY Fastly
$36.47 /

+0.365 (+1.01%)

FSLY Fastly
$36.47 /

+0.365 (+1.01%)

FSLY Fastly
$36.47 /

+0.365 (+1.01%)

FSLY Fastly
$36.47 /

+0.365 (+1.01%)

Downgrade
Novartis downgraded to Neutral on pipeline concerns at Bryan Garnier » 05:46
12/03/21
12/03
05:46
12/03/21
05:46
NVS

Novartis

$79.96 /

+0.11 (+0.14%)

Bryan Garnier analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVS Novartis
$79.96 /

+0.11 (+0.14%)

NVS Novartis
$79.96 /

+0.11 (+0.14%)

05:20 Today Bryan Garnier
Novartis downgraded to Neutral from Buy at Bryan Garnier
11/05/21 UBS
Novartis downgraded to Neutral on lower near-term growth at UBS
11/05/21 UBS
Novartis downgraded to Neutral from Buy at UBS
10/27/21 JPMorgan
Novartis price target lowered to CHF 80 from CHF 84 at JPMorgan
NVS Novartis
$79.96 /

+0.11 (+0.14%)

NVS Novartis
$79.96 /

+0.11 (+0.14%)

NVS Novartis
$79.96 /

+0.11 (+0.14%)

NVS Novartis
$79.96 /

+0.11 (+0.14%)

Upgrade
Marvell upgraded to Outperform from Market Perform at Cowen » 05:40
12/03/21
12/03
05:40
12/03/21
05:40
MRVL

Marvell

$71.02 /

+0.18 (+0.25%)

Cowen analyst Karl…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

05:11 Today Oppenheimer
Marvell price target raised to $110 from $100 at Oppenheimer
12/01/21 Susquehanna
Marvell price target raised to $82 from $75 at Susquehanna
11/30/21 BMO Capital
Marvell price target raised to $85 from $70 at BMO Capital
11/29/21 B. Riley
Marvell price target raised to $90 from $83 at B. Riley
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

Downgrade
Smith & Wesson downgraded to Market Perform from Outperform at Cowen » 05:38
12/03/21
12/03
05:38
12/03/21
05:38
SWBI

Smith & Wesson Brands

$22.94 /

+0.405 (+1.80%)

Cowen analyst Cai Von…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

09/02/21 Lake Street
Smith & Wesson undervalued after 'another strong quarter,' says Lake Street
06/21/21 Lake Street
Smith & Wesson Brands price target raised to $43 from $34 at Lake Street
03/05/21
Fly Intel: Top five analyst downgrades
03/05/21 Lake Street
Smith & Wesson Brands price target raised to $34 from $28 at Lake Street
SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

Hot Stocks
BeiGene announces China NMPA approval for Sylvant » 05:37
12/03/21
12/03
05:37
12/03/21
05:37
BGNE

BeiGene

$346.46 /

-7.365 (-2.08%)

BeiGene announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BGNE BeiGene
$346.46 /

-7.365 (-2.08%)

BGNE BeiGene
$346.46 /

-7.365 (-2.08%)

10/12/21
Fly Intel: Top five analyst initiations
10/12/21 Bernstein
BeiGene initiated with Outperform, $431 price target at Bernstein
10/12/21 Bernstein
BeiGene initiated with an Outperform at Bernstein
10/06/21 CLSA
CLSA double upgrades BeiGene to Buy on anti-BTK potential
BGNE BeiGene
$346.46 /

-7.365 (-2.08%)

BGNE BeiGene
$346.46 /

-7.365 (-2.08%)

BGNE BeiGene
$346.46 /

-7.365 (-2.08%)

Downgrade
Ollie's Bargain Outlet downgraded to Underweight from Neutral at JPMorgan » 05:37
12/03/21
12/03
05:37
12/03/21
05:37
OLLI

Ollie's Bargain Outlet

$63.05 /

+1.9 (+3.11%)

JPMorgan analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OLLI Ollie's Bargain Outlet
$63.05 /

+1.9 (+3.11%)

OLLI Ollie's Bargain Outlet
$63.05 /

+1.9 (+3.11%)

09/08/21
Fly Intel: Top five analyst upgrades
09/08/21 Berenberg
Ollie's Bargain Outlet upgraded to Buy on pullback at Berenberg
09/08/21 Berenberg
Ollie's Bargain Outlet upgraded to Buy from Hold at Berenberg
09/02/21 Piper Sandler
Ollie's shares attractive at current levels, says Piper Sandler
OLLI Ollie's Bargain Outlet
$63.05 /

+1.9 (+3.11%)

OLLI Ollie's Bargain Outlet
$63.05 /

+1.9 (+3.11%)

OLLI Ollie's Bargain Outlet
$63.05 /

+1.9 (+3.11%)

Downgrade
Joann downgraded to Equal Weight from Overweight at Wells Fargo » 05:36
12/03/21
12/03
05:36
12/03/21
05:36
JOAN

Joann

$9.34 /

+0.68 (+7.85%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JOAN Joann
$9.34 /

+0.68 (+7.85%)

JOAN Joann
$9.34 /

+0.68 (+7.85%)

10/01/21 Barclays
Joann downgraded to Underweight from Equal Weight at Barclays
09/20/21 Loop Capital
Joann's updated format easier to shop, says Loop Capital
09/07/21 Loop Capital
Joann price target lowered to $15 from $20 at Loop Capital
09/07/21 Barclays
Joann downgraded to Equal Weight from Overweight at Barclays
JOAN Joann
$9.34 /

+0.68 (+7.85%)

  • 12
    Mar
JOAN Joann
$9.34 /

+0.68 (+7.85%)

JOAN Joann
$9.34 /

+0.68 (+7.85%)

Hot Stocks
BeiGene announces three medicines included in NDRL by China NHSA » 05:35
12/03/21
12/03
05:35
12/03/21
05:35
BGNE

BeiGene

$346.46 /

-7.365 (-2.08%)

BeiGene announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BGNE BeiGene
$346.46 /

-7.365 (-2.08%)

BGNE BeiGene
$346.46 /

-7.365 (-2.08%)

10/12/21
Fly Intel: Top five analyst initiations
10/12/21 Bernstein
BeiGene initiated with Outperform, $431 price target at Bernstein
10/12/21 Bernstein
BeiGene initiated with an Outperform at Bernstein
10/06/21 CLSA
CLSA double upgrades BeiGene to Buy on anti-BTK potential
BGNE BeiGene
$346.46 /

-7.365 (-2.08%)

BGNE BeiGene
$346.46 /

-7.365 (-2.08%)

BGNE BeiGene
$346.46 /

-7.365 (-2.08%)

Downgrade
Marfrig downgraded to Neutral from Outperform at Bradesco BBI » 05:35
12/03/21
12/03
05:35
12/03/21
05:35
MRRTY

Marfrig

$3.89 /

+0.02 (+0.52%)

Bradesco BBI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRRTY Marfrig
$3.89 /

+0.02 (+0.52%)

05/24/21 JPMorgan
Marfrig downgraded to Neutral from Overweight at JPMorgan
12/15/20 Santander
Marfrig downgraded to Underperform from Buy at Santander
Downgrade
JBS S.A. downgraded to Neutral from Outperform at Bradesco BBI » 05:35
12/03/21
12/03
05:35
12/03/21
05:35
JBSAY

JBS S.A.

$12.51 /

+0.45 (+3.73%)

Bradesco BBI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JBSAY JBS S.A.
$12.51 /

+0.45 (+3.73%)

JBSAY JBS S.A.
$12.51 /

+0.45 (+3.73%)

04/22/21 Goldman Sachs
JBS S.A. initiated with a Buy at Goldman Sachs
JBSAY JBS S.A.
$12.51 /

+0.45 (+3.73%)

JBSAY JBS S.A.
$12.51 /

+0.45 (+3.73%)

Hot Stocks
Hutchmed announces China NRDL to include Elunate, Sulanda » 05:34
12/03/21
12/03
05:34
12/03/21
05:34
HCM

Hutchmed

$32.89 /

-1.31 (-3.83%)

Hutchmed announced that,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HCM Hutchmed
$32.89 /

-1.31 (-3.83%)

HCM Hutchmed
$32.89 /

-1.31 (-3.83%)

09/22/21
Fly Intel: Top five analyst downgrades
09/22/21 Goldman Sachs
Hutchmed downgraded to Neutral from Buy at Goldman Sachs
08/03/21 Jefferies
Hutchmed initiated with a Buy at Jefferies
07/13/21 Cantor Fitzgerald
Hutchmed price target raised to $45 from $40 at Cantor Fitzgerald
HCM Hutchmed
$32.89 /

-1.31 (-3.83%)

Upgrade
UiPath upgraded to Overweight from Equal Weight at Morgan Stanley » 05:33
12/03/21
12/03
05:33
12/03/21
05:33
PATH

UiPath

$43.28 /

-0.67 (-1.52%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PATH UiPath
$43.28 /

-0.67 (-1.52%)

PATH UiPath
$43.28 /

-0.67 (-1.52%)

12/01/21 BMO Capital
UiPath price target lowered to $57 from $70 at BMO Capital
11/29/21 Cleveland Research
UiPath initiated with a Neutral at Cleveland Research
11/16/21 Credit Suisse
UiPath initiated with an Outperform at Credit Suisse
10/08/21 Cowen
UiPath price target lowered to $72 from $80 at Cowen
PATH UiPath
$43.28 /

-0.67 (-1.52%)

  • 29
    Jun
  • 18
    Jun
  • 21
    Apr
PATH UiPath
$43.28 /

-0.67 (-1.52%)

PATH UiPath
$43.28 /

-0.67 (-1.52%)

Upgrade
Appian upgraded to Equal Weight from Underweight at Morgan Stanley » 05:33
12/03/21
12/03
05:33
12/03/21
05:33
APPN

Appian

$68.90 /

+0.69 (+1.01%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APPN Appian
$68.90 /

+0.69 (+1.01%)

APPN Appian
$68.90 /

+0.69 (+1.01%)

11/08/21
Fly Intel: Top five analyst upgrades
11/08/21 Truist
Appian upgraded to Buy from Hold at Truist
11/08/21 Truist
Appian upgraded to Buy from Hold at Truist
09/17/21 Barclays
Appian price target raised to $90 from $77 at Barclays
APPN Appian
$68.90 /

+0.69 (+1.01%)

Downgrade
Enel Americas downgraded to Neutral from Overweight at JPMorgan » 05:32
12/03/21
12/03
05:32
12/03/21
05:32
ENIA

Enel Americas

$6.14 /

+0.14 (+2.33%)

JPMorgan analyst Henrique…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENIA Enel Americas
$6.14 /

+0.14 (+2.33%)

ENIA Enel Americas
$6.14 /

+0.14 (+2.33%)

09/29/21 Goldman Sachs
Enel Americas initiated with a Neutral at Goldman Sachs
Hot Stocks
Molecular Partners enters MP0533 research collaboration with University of Bern » 05:31
12/03/21
12/03
05:31
12/03/21
05:31
MOLN

Molecular Partners

$13.75 /

+0.63 (+4.80%)

Molecular Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MOLN Molecular Partners
$13.75 /

+0.63 (+4.80%)

MOLN Molecular Partners
$13.75 /

+0.63 (+4.80%)

08/10/21 Credit Suisse
Molecular Partners price target lowered to CHF 18.50 at Credit Suisse
07/12/21 Cowen
Molecular Partners initiated with an Outperform at Cowen
07/12/21 RBC Capital
Molecular Partners price target lowered to CHF 26 from CHF 28 at RBC Capital
07/12/21 SVB Leerink
Molecular Partners assumed with an Outperform at SVB Leerink
  • 16
    Jun
MOLN Molecular Partners
$13.75 /

+0.63 (+4.80%)

Initiation
Vicat SA initiated with a Hold at Berenberg » 05:30
12/03/21
12/03
05:30
12/03/21
05:30
SDCVF

Vicat SA

$38.40 /

+ (+0.00%)

Berenberg analyst Harry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SDCVF Vicat SA
$38.40 /

+ (+0.00%)

10/07/21 Barclays
Vicat SA price target lowered to EUR 50 from EUR 57 at Barclays
08/03/21 Citi
Vicat SA price target raised to EUR 57 at Citi
05/07/21 Citi
Vicat SA price target raised to EUR 54 from EUR 48 at Citi
02/22/21 Barclays
Vicat SA price target raised to EUR 52 from EUR 45 at Barclays
Initiation
Titan Cement initiated with a Hold at Berenberg » 05:30
12/03/21
12/03
05:30
12/03/21
05:30
TTCIF

Titan Cement

/

+

Berenberg analyst Harry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Oil Action: WTI crude » 05:30
12/03/21
12/03
05:30
12/03/21
05:30
$ECON

Economic Data

/

+

Oil Action: WTI crude…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Himax chairman Biing-Seng Wu to purchase up to $10M of ADSs » 05:29
12/03/21
12/03
05:29
12/03/21
05:29
HIMX

Himax

$10.26 /

+0.23 (+2.29%)

Himax announced that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HIMX Himax
$10.26 /

+0.23 (+2.29%)

09/17/21 Vertical Group
Himax downgraded to Sell from Neutral at Vertical Group
03/09/21 Vertical Group
Himax reinstated with a Neutral at Vertical Group
02/08/21 Northland
Himax price target raised to $13 from $4.50 at Northland
01/27/21 Nomura
Himax upgraded to Buy from Neutral at Nomura
HIMX Himax
$10.26 /

+0.23 (+2.29%)

Downgrade
Amundi downgraded to Neutral from Outperform at Exane BNP Paribas » 05:28
12/03/21
12/03
05:28
12/03/21
05:28
AMDUF

Amundi

$84.10 /

+ (+0.00%)

Exane BNP Paribas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMDUF Amundi
$84.10 /

+ (+0.00%)

11/29/21 Morgan Stanley
Amundi downgraded to Equal Weight from Overweight at Morgan Stanley
07/12/21 Morgan Stanley
Amundi price target raised to EUR 89.60 from EUR 88.40 at Morgan Stanley
07/12/21 Berenberg
Amundi price target raised to EUR 88 from EUR 85 at Berenberg
07/01/21 Deutsche Bank
Amundi price target lowered to EUR 77 from EUR 79 at Deutsche Bank
Hot Stocks
Moody's acquires PassFort, agrees to acquire kompany » 05:27
12/03/21
12/03
05:27
12/03/21
05:27
MCO

Moody's

$389.05 /

+8.72 (+2.29%)

Moody's announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MCO Moody's
$389.05 /

+8.72 (+2.29%)

MCO Moody's
$389.05 /

+8.72 (+2.29%)

10/29/21 Credit Suisse
Moody's price target raised to $475 from $425 at Credit Suisse
10/18/21 BMO Capital
Moody's price target raised to $423 from $415 at BMO Capital
09/07/21 Oppenheimer
Moody's price target raised to $418 from $406 at Oppenheimer
07/29/21
Fly Intel: Top five analyst downgrades
MCO Moody's
$389.05 /

+8.72 (+2.29%)

Upgrade
Vonovia upgraded to Buy from Hold at DZ Bank » 05:27
12/03/21
12/03
05:27
12/03/21
05:27
VNNVF

Vonovia

$57.10 /

+ (+0.00%)

DZ Bank analyst Karsten…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VNNVF Vonovia
$57.10 /

+ (+0.00%)

11/11/21 Goldman Sachs
Vonovia reinstated with a Buy at Goldman Sachs
11/08/21 RBC Capital
Vonovia price target raised to EUR 55 from EUR 54 at RBC Capital
09/15/21 DZ Bank
Vonovia downgraded to Hold from Buy at DZ Bank
08/26/21 Berenberg
Vonovia price target raised to EUR 69 from EUR 66 at Berenberg

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.